- Siemens Healthcare
- Canon Medical Systems
- GE Healthcare
- Philips Healthcare
- 3D Systems
- IMRIS
- Shimadzu
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent Developments in Angio Suites Market:
- In September 2022, Leiden University Medical Center joined the global network of partners with Philips in advancing the evolution of the Philips Spectral Angio CT suite and its usage in clinical research. This partnership brings spectral CT imaging technology into an integrated hybrid angio CT suite to innovate a range of treatment procedures.
- In June 2022, Siemens Healthineers introduced the angiography system Artis icono ceiling for precise tumor embolization. The new system mechanics and image chain for precise 2D and 3D imaging
The rising incidence of cardiovascular conditions, such as coronary artery disease, stroke, and others, is expected to be a primary global health concern, contributing to the market growth. This trend has spurred an increasing demand for advanced medical equipment like angio suites, which are essential in the diagnosis, intervention, and management of these conditions. As healthcare providers increasingly acknowledge the importance of timely and accurate cardiovascular assessments, the need for high-quality imaging and diagnostic tools is crucial, further propelling the market growth. Moreover, incorporating AI and machine learning into medical imaging presents an opportunity for the angio suites market. These technologies have the potential to transform the way cardiovascular conditions are diagnosed and treated. By leveraging AI and ML algorithms, angio suites may analyze complex imaging data with remarkable speed and precision, facilitating more accurate and early detection of cardiovascular abnormalities. Also, these advanced algorithms can help in treatment planning by providing valuable insights into personalized therapeutic approaches. Therefore, driving the market expansion. However, the high cost of angio suites may significantly hinder the widespread adoption of the market. While invaluable in delivering precise diagnoses and treatments, these advanced medical instruments bear a hefty financial burden. These financial expenses might be challenging for smaller healthcare facilities, usually constrained by limited budgets. Additionally, healthcare institutions in developing regions, struggling with resource limitations, may struggle to allocate substantial funds toward developing and maintaining angio suites, further hindering market growth.